Is 603477 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6
Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 603477 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 603477 (CN¥19.14) is trading below our estimate of fair value (CN¥121.06)
Significantly Below Fair Value: 603477 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 603477?
Key metric: As 603477 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for 603477. This is calculated by dividing 603477's market cap by their current
revenue.
What is 603477's PS Ratio?
PS Ratio
2x
Sales
CN¥4.99b
Market Cap
CN¥9.76b
603477 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
603363 Fujian Aonong Biological Technology Group Incorporation
0.3x
n/a
US$448.41m
5 Companies
Estimated Growth
Market Cap
No more companies
Price-To-Sales vs Industry: 603477 is expensive based on its Price-To-Sales Ratio (2x) compared to the CN Food industry average (1.8x).
Price to Sales Ratio vs Fair Ratio
What is 603477's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
603477 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
2x
Fair PS Ratio
2.5x
Price-To-Sales vs Fair Ratio: 603477 is good value based on its Price-To-Sales Ratio (2x) compared to the estimated Fair Price-To-Sales Ratio (2.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst 603477 forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
CN¥19.14
CN¥31.31
+63.6%
35.4%
CN¥47.00
CN¥23.00
n/a
3
Nov ’25
CN¥20.06
CN¥31.31
+56.1%
35.4%
CN¥47.00
CN¥23.00
n/a
3
Oct ’25
CN¥21.60
CN¥31.31
+45.0%
35.4%
CN¥47.00
CN¥23.00
n/a
3
Sep ’25
CN¥17.87
CN¥31.31
+75.2%
35.4%
CN¥47.00
CN¥23.00
n/a
3
Aug ’25
CN¥21.76
CN¥46.47
+113.5%
5.7%
CN¥49.40
CN¥43.00
n/a
3
Jul ’25
CN¥29.77
CN¥46.47
+56.1%
5.7%
CN¥49.40
CN¥43.00
n/a
3
Jun ’25
CN¥33.03
CN¥46.47
+40.7%
5.7%
CN¥49.40
CN¥43.00
n/a
3
May ’25
CN¥34.82
CN¥46.47
+33.4%
5.7%
CN¥49.40
CN¥43.00
n/a
3
Apr ’25
CN¥36.93
CN¥46.47
+25.8%
5.7%
CN¥49.40
CN¥43.00
n/a
3
Mar ’25
CN¥32.20
CN¥43.13
+34.0%
10.3%
CN¥49.40
CN¥40.00
n/a
3
Feb ’25
CN¥31.18
CN¥45.47
+45.8%
8.8%
CN¥49.40
CN¥40.00
n/a
3
Jan ’25
CN¥37.47
CN¥45.47
+21.3%
8.8%
CN¥49.40
CN¥40.00
n/a
3
Dec ’24
CN¥33.09
CN¥39.00
+17.9%
2.6%
CN¥40.00
CN¥38.00
n/a
2
Nov ’24
CN¥32.29
CN¥39.00
+20.8%
2.6%
CN¥40.00
CN¥38.00
CN¥20.06
2
Oct ’24
CN¥27.47
CN¥36.50
+32.9%
9.6%
CN¥40.00
CN¥33.00
CN¥21.60
2
Sep ’24
CN¥26.31
CN¥36.50
+38.7%
9.6%
CN¥40.00
CN¥33.00
CN¥17.87
2
Aug ’24
CN¥31.38
CN¥39.00
+24.3%
2.6%
CN¥40.00
CN¥38.00
CN¥21.76
2
Jul ’24
CN¥33.35
CN¥36.50
+9.4%
4.1%
CN¥38.00
CN¥35.00
CN¥29.77
2
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.